Aqua Bio Technology — Share Issue/Capital Change 2023

Aug 16, 2023

Aqua Bio Technology ASA - Closing Conditions Met for Skinteam Acquisition - Reminder on subscription period in Subsequent Offering

Aqua Bio Technology ASA - Closing Conditions Met for Skinteam Acquisition - Reminder on subscription period in Subsequent Offering

16.8.2023 16:51:44 CEST | Aqua Bio Technology ASA | Non-regulatory press

releases

Reference is made to the stock exchange announcements made by Aqua Bio

Technology ASA ("ABTEC" or the "Company") on 3 August 2023 regarding, among

other things, the share purchase agreement ABTEC entered with the shareholders

of Skinteam Norge AS ("Skinteam") with respect to ABTEC acquiring all of the

shares in Skinteam (the "SPA") (the "Acquisition").

The closing conditions according to the SPA have now been satisfied, and ABTEC

has been registered as owner of all of the shares in Skinteam.

Reference is further made to the stock exchange announcement made by ABTEC on 8

August 2023 regarding the commencement of a subsequent offering of up to

1,666,667 new shares ("Offer Shares") in the Company to certain eligible

shareholders (the "Subsequent Offering").

The subscription period in the Subsequent Offering will conclude on 18 August

2023 at 16:30 hours (CEST). Subscription rights that are not used to subscribe

for Offer Shares before this deadline will have no value and will expire without

any compensation to the holder.

For further information, please contact CEO Håvard Lindstrøm mobile phone +47

941 32 288.

About ABTEC

Aqua Bio Technology (ABTEC) is developing and commercializing sustainable

biotechnology for use in skin care products. ABTEC's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABTEC is also marketing and

distributing natural skin care products developed by partners towards consumers

and professional users. Aqua Bio Technology is listed on Euronext Expand.

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2546/3543/Download%20announcement

%20as%20PDF.pdf